Index
- Peptone: finding opportunity in disorder
- All Pregnant Women Should Be Screened for Blood-Pressure Disorders, U.S. Advisers Say
- Equip nabs additional investment to expand virtual eating disorder treatment services to adult patients
- Neumora Therapeutics Announces Pricing of Initial Public Offering
- Owkin and Tribun Health Launch Strategic Partnership to Accelerate Access to AI Solutions for Diagnosis and Pharma Research
- Beam Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of BEAM-201 in Relapsed, Refractory T-ALL/T-LL
- Eleos Health and KCare Join Forces to Improve Clinician Support with CareOps Automation
- Substance-use treatment startup Better Life Partners completes $26.5M Series B fundraise
- Comanche Biopharma Named by Fierce Biotech as a “Fierce 15” Biotech Company of 2023
- Comanche Biopharma Receives US FDA Fast Track Designation for CBP-4888 for the Treatment of sFlt-1 mediated pre-term preeclampsia
- Firefly grows in wake of healthcare disruptions in southeastern Mass.
- Madaket Health Releases Provider Data Exchange to Help Payers Remain Compliant with the No Surprises Act
- TraceLink Collaborates with GS1 US to Author GS1 US Addendum Guidance and XML Examples for GS1 US DSCSA Implementation Guideline R1.3 to Support EPCIS Data Exchange
- Innovent Announces the NMPA Approval of SINTBILO® (Tafolecimab Injection) for the Treatment of Adult Patients with Primary Hypercholesterolemia and Mixed Dyslipidemia
- Radiopharmaceuticals for cancer: Making radiation precise
- Health Plan Alliance Selects 1upHealth as Preferred Health Data Interoperability Partner
- Memorial Hermann Health System Makes a Strategic Investment in Capital Rx Customer Solutions Platform
- SoftBank-backed Proximie launches virtual robotic-assisted surgery training course
- Talkiatry and NOCD Team up to Strengthen OCD Care Journeys
- Simon Data Raises Series D Funding Round to Further Develop World’s First Fully-Connected CDP
- Better Life Partners Lands $26.5M for Virtual SUD, Mental Health Platform
- Avalyn Pharma Expands Executive Team with Appointment of Howard M. Lazarus, MD, FCCP to the Role of Chief Medical Officer
- Talkiatry, NOCD Strike Partnership To Support Patients With OCD
- Born out of Omega push for pandemic treatments, Aerium Therapeutics enters long Covid R&D
- With ISO certification, Owkin demonstrates commitment to utmost quality with its AI solutions for digital pathology
- Sironax Announces Closing of $200 Million Series B Financing
- Member Spotlight: F-Prime Capital
- Avalyn Pharma Invited to Present at Canaccord Genuity Annual Growth Conference
- Patina teams with Humana to expand reach of convenient, relationship-centered primary care for people with Medicare
- Invetx Completes Development of Canine and Feline Half-Life Extension Technology Platform that Significantly Extends Duration of Monoclonal Antibody Treatment Effect
- VR helps brain tumor patients overcome “scanxiety” before brain scans, study finds
- Bicara Therapeutics Expands Management Team with the Appointment of David Raben, M.D., as Chief Medical Officer
- ARTBIO and SpectronRx Enter a Collaboration to Manufacture Key Components of ARTBIO’s AlphaDirect™ Technology
- AppliedVR and National Cancer Institute Collaborate on Research Evaluating Virtual Reality for Reducing Anxiety in Primary Brain Tumor Patients During Imaging Services
- Centivo Launches Partnership with SSM Health
- Tenpoint Therapeutics launches with $70M to restore vision with stem cell therapies and ‘reprogramming’ medicines
- NodThera is first to demonstrate reduction in neuroinflammation in the clinic with brain penetrant NLRP3 inflammasome inhibitor
- Zus Health Joins Civitas Networks for Health
- Patina brings innovative primary care for people 65+ to Charlotte region; designed to help individuals thrive & remain independent
- Ultragenyx Announces First Patients Dosed in Phase 3 Program Evaluating Setrusumab (UX143) for the Treatment of Osteogenesis Imperfecta (OI)
- Centivo Launches Partnership with SSM Health in the Fond du Lac Market to Offer Wisconsin Businesses and Employees More Affordable, High-Quality Healthcare
- China NMPA approves RareStone’s pitolisant (Wakix) for the treatment of narcolepsy
- Skyline Therapeutics Receives FDA Clearance of IND for SKG0106, a Novel Intravitreally Delivered AAV Gene Therapy Candidate for Neovascular Age-related Macular Degeneration
- Innovent and IASO Bio Announce the NMPA Approval of FUCASO®, the First Fully-human BCMA CAR-T Therapy, for the Treatment of Relapsed or Refractory Multiple Myeloma
- F-Prime’s Ketan Patel on ‘reverse ageism’ in biotech and investing in a downturn
- K36 Therapeutics raises $70M in Series B to fund multiple myeloma research
- K36 Therapeutics Announces $70 Million Series B Financing to Fund Clinical Proof of Concept of KTX-1001, First-in-class Inhibitor of MMSET for Treatment of Multiple Myeloma Patients with Genetic Translocation (4;14)
- Menopause care is still a largely untapped market. Here’s why investors and startups should dive in
- First AI-generated drug enters human clinical trials, targeting chronic lung disease patients
- Biotech begins human trials of drug designed by artificial intelligence
- First Drug Discovered and Designed with Generative AI Enters Phase II Trials, with First Patients Dosed
- Harvard Medical School, RareCyte developing multiplex imaging for clinical pathology
- Invetx Appoints Dr. Marcus Remmers, Novo Holdings Partner and Animal Health Industry Leader, to Board of Directors
- Castor Appoints New CFO to Drive Transformative Growth
- Innovent and RemeGen Enter into Clinical Trial Collaboration Investigating Combination Therapy of TYVYT® (sintilimab injection) and Novel ADC Candidates for Advanced Solid Tumors in China
- TIME100 Most Influential Companies 2023: Equip
- Precision BioSciences Announces Oral Presentation of Positive ARCUS® Gene Editing Data at International Liver Congress 2023
- ARTBIO: manufacturing strategy to lead on lead-212 radiotherapies
- Ultragenyx opens new gene therapy manufacturing site in Massachusetts
- ARTBIO Launches to Develop New Class of Alpha Radioligand Therapies Designed to Maximize Therapeutic Potential
- ARTBIO emerges with $23M to make radioligand therapies for prostate cancer, with field still in ‘early days’
- WelbeHealth’s Michael Le On The Future Of Innovative At-Home Care Models
- Silver Cross Hospital Expands Use of Kyruus’ Award-Winning Online Scheduling Solution Across Specialties and Services
- India’s Enzene Biosciences unveils $50M New Jersey plant project, plans to hire 300
- Equip Names Nikia Bergan as the Company’s First President
- Equip taps healthcare exec Nikia Bergan as new president to scale up virtual eating disorder treatment services
- Denali Therapeutics Announces Robust Reduction in Neurofilament Light (NfL) with DNL310 (ETV:IDS) Treatment in MPS II (Hunter Syndrome)
- NodThera announces positive first-in-human data for two brain penetrant NLRP3 inflammasome inhibitors
- Doceree launches industry-first HCP-focused global DSP for media agencies at Cannes Lions 2023
- With $50M Investment in MOSAIC Project, Owkin Seeks to Become Cancer ‘Drug Discovery Enterprise’
- Eleos Health Partners with Trilogy, Adds COO to Customer Advisory Board
- Owkin Rolls Out Its Landmark AI Diagnostic Within Medipath, the Largest Network of Pathologists in France
- Wedgewood Pharmacy Merges with Blue Rabbit to Deliver Exceptional Veterinary Pharmacy Services Nationwide
- BHB Value: The Pursuit of High Quality Applied Behavior Analysis
- Comanche Biopharma Strengthens Board of Directors with Appointment of Dr. Ann Taylor
- Albert Invent Raises $7.5 Million Seed, Led by Index Ventures, to Bring New Products to Market Faster Than Ever Before
- Game-changing pan-TEAD inhibitor for solid tumours
- The fertility business is booming as startups go after big profits in a $54 billion market, even as other healthcare companies slump
- Pulmocide Announces Expansion of Management Team
- Equip Partnership Adds Eating Disorder Support to Accolade’s Trusted Partner Ecosystem
- Pregnant and over 40? You aren’t alone. More women are becoming later-in-life moms.
- Benchling Delivers an Integrated R&D Ecosystem with New Product Offerings
- Early data show Bicara’s bispecific helps shrink head and neck cancers when combined with Keytruda: #ASCO23
- Bicara Therapeutics’ First-in-class Bifunctional EGFR/TGF-β Inhibitor, BCA101, Demonstrates 65% ORR in Combination with Pembrolizumab in 1L HPV-negative Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
- Insilico Medicine describes new USP1 inhibitors for cancer
- Long-term optimism, but short-term worry among Mass. biotech VCs
- PlasmaGen Biosciences to invest in Karnataka for advanced blood plasma production unit
- WelbeHealth Continues Los Angeles Expansion With Opening of New PACE Centers in Rosemead and North Hollywood
- Insilico Medicine divulges new 3CLpro inhibitors for SARS-CoV-2
- TraceLink Ensures DSCSA Verification Readiness and End-to-End VRS Support for Pharmaceutical Supply Chain Members Amid Vendor Turbulence